Genistein suppresses prostate cancer growth through inhibition of oncogenic MicroRNA-151

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Chiyomaru, Takeshi ^a   Yamamura, Soichiro ^a   Zaman, Mohd Saif ^a   Majid, Shahana ^a   Deng, Guoren ^a   Shahryari, Varahram ^a   Saini, Sharanjot ^a   Hirata, Hiroshi ^a   Ueno, Koji ^a   Chang, Inik ^a   Tanaka, Yuichiro ^a   Tabatabai, Z Laura ^b   Enokida, Hideki ^c   Nakagawa, Masayuki ^c   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; MICRORNA; MICRORNA 151; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARHGDIA GENE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CASZ1 GENE; CELL INVASION; CELL MIGRATION; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IL1RAPL1 GENE; MALE; METASTASIS; N4BP1 GENE; NUCLEOTIDE BINDING SITE; SOX17 GENE; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; AGED; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GENISTEIN; HUMANS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENES; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 84865287011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043812     Document Type: Article

References (43)

1. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Nelson CJ, Lee JS, Gamboa MC, Roth AJ, (2008) Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer 113: 1097-1106.
3. Brodersen P, Voinnet O, (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10: 141-148.
4. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
5. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: The implications for cancer research. Nat Rev Cancer 10: 389-402.
6. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
7. Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, et al. (2011) LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. Br J Cancer 104: 376-386.
8. Monzon FA, Alvarez K, Peterson L, Truong L, Amato RJ, et al. (2011) Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis. Mod Pathol 24: 1470-1479.
9. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11-22.
10. Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, et al. (2007) Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Res 67: 818-826.
11. Wong MP, Fung LF, Wang E, Chow WS, Chiu SW, et al. (2003) Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers. Cancer 97: 1263-1270.
12. Uchida M, Tsukamoto Y, Uchida T, Ishikawa Y, Nagai T, et al. (2010) Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol 221: 96-105.
13. Lips EH, van Eijk R, de Graaf EJ, Oosting J, de Miranda NF, et al. (2008) Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis. BMC Cancer 8: 314.
14. Barnabas N, Xu L, Savera A, Hou Z, Barrack ER, (2011) Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene. Prostate 71: 857-871.
15. de Souza PL, Russell PJ, Kearsley JH, Howes LG, (2010) Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutr Rev 68: 542-555.
16. Pavese JM, Farmer RL, Bergan RC, (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29: 465-482.
17. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, et al. (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57: 190-205.
18. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, et al. (2004) Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34: 86-89.
19. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, et al. (2007) Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 16: 538-545.
20. Nagata Y, Sonoda T, Mori M, Miyanaga N, Okumura K, et al. (2007) Dietary isoflavones may protect against prostate cancer in Japanese men. J Nutr 137: 1974-1979.
21. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, et al. (2004) Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95: 65-71.
22. Yan L, Spitznagel EL, (2009) Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89: 1155-1163.
23. Liu Z, Yang X, Li Z, McMahon C, Sizer C, et al. (2011) CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ 18: 1174-1183.
24. McAvoy S, Ganapathiraju S, Perez DS, James CD, Smith DI, (2007) DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors. Cytogenet Genome Res 119: 196-203.
25. Jia Y, Yang Y, Liu S, Herman JG, Lu F, et al. (2010) SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Epigenetics 5: 743-749.
26. Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, et al. (2008) Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res 68: 10178-10186.
27. Zhu Y, Tummala R, Liu C, Nadiminty N, Lou W, et al. (2012) RhoGDIα suppresses growth and survival of prostate cancer cells. Prostate 72: 392-398.
28. Caren H, Fransson S, Ejeskar K, Kogner P, Martinsson T, (2007) Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumors. Br J Cancer 97: 1416-1424.
29. Liu C, Chalmers D, Maki R, De Souza EB, (1996) Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J Neuroimmunol 66: 41-48.
30. Smith DI, Zhu Y, McAvoy S, Kuhn R, (2006) Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232: 48-57.
31. Bowles J, Schepers G, Koopman P, (2000) Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227: 239-255.
32. Ye YW, Wu JH, Wang CM, Zhou Y, Du CY, et al. (2011) Sox17 regulates proliferation and cell cycle during gastric cancer progression. Cancer Lett 307: 124-131.
33. Zhang W, Glockner SC, Guo M, Machida EO, Wang DH, et al. (2008) Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 68: 2764-2772.
34. Murillas R, Simms KS, Hatakeyama S, Weissman AM, Kuehn MR, (2002) Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase. J Biol Chem 277: 2897-2907.
35. Oberst A, Malatesta M, Aqeilan RI, Rossi M, Salomoni P, et al. (2007) The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. Proc Natl Acad Sci U S A 104: 11280-11285.
36. Dovas A, Couchman JR, (2005) Rho GDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 390: 1-9.
37. Barone I, Brusco L, Gu G, Selever J, Beyer A, et al. (2011) Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α. J Natl Cancer Inst 103: 538-552.
38. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, et al. (2012) Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One 7: e31060.
39. Sun Q, Cong R, Yan H, Gu H, Zeng Y, et al. (2009) Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol Rep 22: 563-567.
40. Chen Y, Zaman MS, Deng G, Majid S, Saini S, et al. (2011) MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 4: 76-86.
41. Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, et al (2010) miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70: 1486-1495.
42. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, et al. (2010) Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res 70: 2809-2818.
43. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, et al. (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891.